Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Charles Quick

Concepts (405)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endometrial Neoplasms
18
2021
143
4.170
Why?
Vulvar Neoplasms
6
2024
60
2.580
Why?
Carcinoma, Squamous Cell
9
2024
330
2.060
Why?
Carcinoma in Situ
7
2022
72
1.810
Why?
Uterine Neoplasms
10
2023
59
1.810
Why?
Carcinoma, Endometrioid
6
2021
38
1.500
Why?
Adenocarcinoma
10
2024
401
1.460
Why?
Tumor Suppressor Protein p53
3
2024
224
1.380
Why?
PAX2 Transcription Factor
7
2015
24
1.330
Why?
Ovarian Neoplasms
10
2024
458
1.100
Why?
Uterine Cervical Neoplasms
7
2024
299
1.090
Why?
Endometrial Hyperplasia
4
2019
14
1.050
Why?
Cannabidiol
6
2024
43
1.010
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2024
62
1.000
Why?
Stromal Cells
2
2016
77
0.950
Why?
Female
66
2024
28055
0.850
Why?
Sarcoma, Alveolar Soft Part
1
2023
1
0.830
Why?
Plant Extracts
6
2024
194
0.810
Why?
Myometrium
2
2013
13
0.790
Why?
Endometrium
6
2023
43
0.760
Why?
Adenocarcinoma, Clear Cell
6
2019
34
0.720
Why?
Immunohistochemistry
16
2024
975
0.700
Why?
Precancerous Conditions
3
2019
85
0.700
Why?
Cannabis
6
2024
150
0.690
Why?
Aged, 80 and over
20
2024
3382
0.670
Why?
Middle Aged
35
2024
13028
0.650
Why?
Humans
70
2024
52114
0.640
Why?
Cystadenocarcinoma, Serous
4
2013
73
0.640
Why?
Peripheral Nerves
2
2015
43
0.580
Why?
Mutation
9
2024
1318
0.550
Why?
Aged
29
2024
10142
0.540
Why?
Placenta
6
2021
152
0.530
Why?
Cervix Uteri
2
2017
49
0.520
Why?
Adult
31
2024
14095
0.510
Why?
Epithelial-Mesenchymal Transition
2
2016
57
0.510
Why?
Adenosarcoma
1
2016
3
0.510
Why?
Polyps
1
2016
21
0.500
Why?
Uterine Cervical Dysplasia
1
2016
51
0.480
Why?
Lymphatic Metastasis
6
2019
210
0.470
Why?
Neoplasm Staging
9
2024
766
0.470
Why?
Papillomavirus Infections
3
2024
171
0.460
Why?
Fallopian Tubes
2
2012
23
0.460
Why?
Fibroma
1
2015
40
0.460
Why?
Tumor Microenvironment
4
2021
246
0.460
Why?
Prognosis
11
2024
2093
0.420
Why?
Neoplasm Invasiveness
6
2019
277
0.410
Why?
Observer Variation
4
2024
131
0.410
Why?
Pelvic Neoplasms
1
2011
13
0.360
Why?
Uterus
3
2023
88
0.360
Why?
Lymphocytes, Tumor-Infiltrating
3
2021
78
0.360
Why?
Mice, Inbred C57BL
7
2024
1872
0.340
Why?
Ejaculatory Ducts
1
2010
3
0.330
Why?
Seminal Vesicles
1
2010
13
0.330
Why?
Neoplasm Recurrence, Local
4
2015
630
0.330
Why?
Spectrum Analysis, Raman
2
2021
42
0.320
Why?
Reproducibility of Results
5
2024
1214
0.320
Why?
Prostate
1
2010
116
0.310
Why?
Mice
16
2024
5877
0.310
Why?
Bromcresol Purple
1
2009
3
0.310
Why?
Electrophoresis, Capillary
1
2009
10
0.300
Why?
Serum Albumin
1
2009
57
0.300
Why?
Human papillomavirus 16
2
2021
44
0.300
Why?
Methionine
2
2020
136
0.290
Why?
beta Catenin
2
2021
103
0.280
Why?
Predictive Value of Tests
5
2024
939
0.280
Why?
Disease Progression
4
2020
866
0.280
Why?
Liver
4
2024
1154
0.280
Why?
Diabetes Mellitus
2
2023
316
0.270
Why?
Genital Neoplasms, Female
2
2018
48
0.270
Why?
Papillomavirus Vaccines
2
2021
69
0.270
Why?
Anus Neoplasms
2
2018
25
0.270
Why?
Cell Proliferation
4
2021
1017
0.260
Why?
Metaplasia
2
2019
15
0.260
Why?
Antigens, CD
2
2019
215
0.260
Why?
Diagnosis, Differential
8
2020
1031
0.260
Why?
Prostatic Neoplasms
1
2010
396
0.250
Why?
Colitis
2
2020
49
0.250
Why?
Melanoma
2
2020
278
0.250
Why?
Polyethylene Glycols
2
2017
91
0.240
Why?
Neoplasm Grading
5
2021
125
0.240
Why?
Gold
2
2017
84
0.240
Why?
Animals
17
2024
13332
0.240
Why?
Hypertension
2
2021
565
0.240
Why?
Chi-Square Distribution
2
2016
292
0.230
Why?
Proteomics
3
2017
325
0.230
Why?
Nanoparticles
2
2017
127
0.230
Why?
Aspartic Acid Endopeptidases
2
2015
16
0.220
Why?
Young Adult
7
2024
4307
0.220
Why?
Lab-On-A-Chip Devices
1
2024
10
0.220
Why?
Racemases and Epimerases
2
2015
18
0.220
Why?
Sex Cord-Gonadal Stromal Tumors
1
2024
3
0.220
Why?
Retrospective Studies
11
2020
6610
0.220
Why?
Carcinoma, Neuroendocrine
1
2024
25
0.210
Why?
Neuroendocrine Tumors
1
2024
23
0.210
Why?
DNA Mutational Analysis
3
2024
179
0.210
Why?
Head and Neck Neoplasms
2
2019
285
0.210
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2024
42
0.210
Why?
Kidney Neoplasms
2
2018
182
0.210
Why?
Chlamydia muridarum
1
2024
39
0.200
Why?
Homeodomain Proteins
1
2024
80
0.200
Why?
Lung Neoplasms
2
2019
624
0.200
Why?
Endometriosis
1
2023
15
0.200
Why?
Chlamydia Infections
1
2024
75
0.200
Why?
Gynecology
2
2020
52
0.200
Why?
Adenocarcinoma, Sebaceous
1
2022
7
0.200
Why?
Sebaceous Gland Neoplasms
1
2022
16
0.190
Why?
CD4-Positive T-Lymphocytes
1
2024
163
0.190
Why?
Hepatocytes
2
2024
190
0.190
Why?
Fallopian Tube Neoplasms
2
2012
15
0.190
Why?
Immunotherapy
2
2021
240
0.190
Why?
Gestational Trophoblastic Disease
2
2012
2
0.180
Why?
CTLA-4 Antigen
1
2021
23
0.180
Why?
Genotype
2
2021
563
0.180
Why?
Estrogens
2
2023
223
0.180
Why?
Fetal Membranes, Premature Rupture
1
2021
22
0.180
Why?
Oncogene Fusion
1
2021
4
0.180
Why?
PTEN Phosphohydrolase
3
2020
55
0.180
Why?
Leiomyosarcoma
1
2021
22
0.170
Why?
Transcription Factors
3
2020
564
0.170
Why?
Diabetes, Gestational
1
2021
52
0.170
Why?
Cancer Vaccines
1
2021
78
0.170
Why?
Carcinosarcoma
2
2017
18
0.170
Why?
Infant, Small for Gestational Age
1
2020
35
0.160
Why?
Carcinoma, Papillary
1
2020
50
0.160
Why?
Neoplasms, Experimental
1
2020
112
0.160
Why?
Carcinoma, Transitional Cell
1
2020
54
0.160
Why?
Pregnancy in Diabetics
1
2020
25
0.160
Why?
Colonic Neoplasms
1
2021
162
0.160
Why?
Dermatology
1
2020
53
0.160
Why?
Carcinoma, Signet Ring Cell
1
2019
14
0.160
Why?
Radiotherapy
1
2020
128
0.160
Why?
Carcinoma, Lewis Lung
1
2019
10
0.160
Why?
Pregnancy Complications, Neoplastic
1
2019
23
0.160
Why?
Placenta Diseases
1
2019
15
0.160
Why?
Premature Birth
1
2021
150
0.160
Why?
Carcinoma, Renal Cell
2
2018
112
0.160
Why?
Skin Diseases
1
2020
116
0.160
Why?
Melanoma, Experimental
1
2019
34
0.150
Why?
T-Lymphocytes
1
2021
316
0.150
Why?
Hodgkin Disease
1
2019
46
0.150
Why?
Odds Ratio
3
2015
564
0.150
Why?
Hepatic Veno-Occlusive Disease
1
2019
11
0.150
Why?
DNA Polymerase II
1
2019
9
0.150
Why?
DNA Mismatch Repair
1
2019
18
0.150
Why?
Fetal Diseases
1
2019
63
0.150
Why?
Monocytes
1
2019
126
0.150
Why?
Inflammation
2
2020
641
0.150
Why?
Sarcoma
1
2020
70
0.150
Why?
Pregnancy
7
2021
2658
0.150
Why?
Urinary Bladder Neoplasms
1
2020
165
0.150
Why?
CD8-Positive T-Lymphocytes
1
2019
128
0.150
Why?
Methionine Adenosyltransferase
1
2018
19
0.150
Why?
Metformin
1
2020
80
0.150
Why?
Radiation Tolerance
1
2019
78
0.140
Why?
Logistic Models
3
2015
925
0.140
Why?
Disease Models, Animal
6
2020
1467
0.140
Why?
Nuclear Proteins
1
2020
246
0.140
Why?
Programmed Cell Death 1 Receptor
1
2018
39
0.140
Why?
DNA Helicases
1
2020
148
0.140
Why?
Neural Cell Adhesion Molecule L1
1
2017
1
0.140
Why?
Rhabdomyosarcoma
1
2018
12
0.140
Why?
Intestinal Mucosa
2
2020
222
0.140
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
68
0.140
Why?
Hypoglycemic Agents
1
2020
217
0.140
Why?
Pathology, Molecular
1
2017
27
0.140
Why?
Tumor Necrosis Factor-alpha
2
2019
392
0.140
Why?
Biopsy
5
2020
599
0.140
Why?
Neoplastic Cells, Circulating
1
2017
34
0.130
Why?
Pregnancy Complications
1
2021
401
0.130
Why?
Osteosarcoma
1
2017
44
0.130
Why?
Time Factors
3
2021
2970
0.130
Why?
DNA-Binding Proteins
2
2016
424
0.130
Why?
Vimentin
1
2016
32
0.130
Why?
Papillomaviridae
1
2017
104
0.130
Why?
Acetaminophen
1
2019
277
0.130
Why?
Oligonucleotide Array Sequence Analysis
1
2017
411
0.120
Why?
Gene Expression Profiling
2
2019
1101
0.120
Why?
Cadherins
1
2016
62
0.120
Why?
Viral Load
1
2016
80
0.120
Why?
Flow Cytometry
1
2017
397
0.120
Why?
Skin Neoplasms
1
2020
499
0.120
Why?
Male
11
2024
26652
0.120
Why?
Hepatocyte Nuclear Factor 1-beta
1
2015
5
0.120
Why?
Neoplasms, Muscle Tissue
1
2015
12
0.110
Why?
Classification
1
2015
12
0.110
Why?
Colposcopy
1
2015
17
0.110
Why?
Malate Dehydrogenase
1
2014
8
0.110
Why?
Class I Phosphatidylinositol 3-Kinases
3
2024
17
0.110
Why?
Lipogenesis
1
2014
31
0.110
Why?
Cytosol
1
2014
80
0.110
Why?
World Health Organization
1
2015
57
0.110
Why?
Mice, Inbred BALB C
3
2021
307
0.110
Why?
Adolescent
4
2024
6681
0.110
Why?
Multiple Myeloma
1
2009
2999
0.110
Why?
Neoplasm, Residual
1
2015
170
0.110
Why?
Histones
1
2016
316
0.110
Why?
Mammary Neoplasms, Experimental
1
2015
122
0.110
Why?
Obesity
1
2022
1183
0.110
Why?
High-Throughput Nucleotide Sequencing
3
2021
174
0.110
Why?
Antineoplastic Agents
2
2021
1214
0.110
Why?
Gastrointestinal Tract
1
2014
109
0.100
Why?
Intestines
1
2014
154
0.100
Why?
Cell Line, Tumor
4
2020
1418
0.100
Why?
Oncogenes
1
2013
60
0.100
Why?
Patient Selection
1
2015
265
0.100
Why?
Pancreatic Neoplasms
1
2015
202
0.100
Why?
Membrane Proteins
1
2015
328
0.100
Why?
Clusterin
1
2012
8
0.100
Why?
Dose-Response Relationship, Drug
3
2024
1368
0.100
Why?
Risk Factors
3
2015
3922
0.100
Why?
Histocytochemistry
1
2012
44
0.090
Why?
Receptors, Vascular Endothelial Growth Factor
1
2012
24
0.090
Why?
Strongyloidiasis
1
2012
9
0.090
Why?
Follow-Up Studies
2
2016
2282
0.090
Why?
Treatment Outcome
3
2021
5456
0.090
Why?
Cytomegalovirus Infections
1
2012
36
0.090
Why?
Prednisone
1
2012
102
0.090
Why?
Vascular Endothelial Growth Factor A
1
2012
187
0.090
Why?
Tissue Inhibitor of Metalloproteinases
1
2011
11
0.090
Why?
Teratoma
1
2011
24
0.090
Why?
Matrix Metalloproteinases
1
2011
47
0.090
Why?
Sensitivity and Specificity
3
2020
871
0.090
Why?
Adenoma, Oxyphilic
1
2010
11
0.090
Why?
Image Processing, Computer-Assisted
1
2012
239
0.080
Why?
Phenotype
3
2019
794
0.080
Why?
Tissue Array Analysis
3
2015
45
0.080
Why?
Glucocorticoids
1
2012
236
0.080
Why?
Tumor Cells, Cultured
2
2021
445
0.080
Why?
Epigenesis, Genetic
1
2012
401
0.080
Why?
Pilot Projects
2
2023
712
0.080
Why?
Infant, Newborn
3
2021
2859
0.080
Why?
Pregnancy Outcome
2
2021
251
0.070
Why?
Phosphatidylinositol 3-Kinases
2
2024
149
0.070
Why?
Necrosis
2
2024
169
0.070
Why?
Telemedicine
1
2015
492
0.070
Why?
Cell Differentiation
2
2024
670
0.070
Why?
Hysterectomy
2
2021
90
0.070
Why?
Cell Nucleus
2
2021
188
0.070
Why?
Host-Pathogen Interactions
2
2021
131
0.070
Why?
Societies, Medical
2
2019
200
0.070
Why?
Neoplasms
1
2017
1288
0.070
Why?
Gene Expression Regulation
3
2023
1000
0.070
Why?
Consensus
2
2020
190
0.060
Why?
Ventricular Pressure
1
2006
16
0.060
Why?
Isoproterenol
1
2006
55
0.060
Why?
Terminology as Topic
2
2018
69
0.060
Why?
Kaplan-Meier Estimate
2
2018
482
0.060
Why?
Serum Response Factor
1
2006
45
0.060
Why?
Combined Modality Therapy
2
2020
634
0.060
Why?
Kidney
1
2010
713
0.060
Why?
Practice Guidelines as Topic
2
2019
494
0.060
Why?
Neoplasm Metastasis
2
2018
236
0.060
Why?
Cytokines
2
2020
621
0.060
Why?
Cells, Cultured
2
2021
1568
0.060
Why?
Proportional Hazards Models
2
2017
439
0.060
Why?
Chromatography, Liquid
2
2016
239
0.060
Why?
Bilirubin
1
2024
44
0.050
Why?
Tandem Mass Spectrometry
2
2016
249
0.050
Why?
Species Specificity
1
2024
191
0.050
Why?
Heart
1
2006
360
0.050
Why?
Steroids
1
2024
60
0.050
Why?
Interleukin-10
1
2024
81
0.050
Why?
Th1 Cells
1
2024
52
0.050
Why?
Gene Expression Regulation, Neoplastic
2
2018
853
0.050
Why?
Phylogeny
1
2024
229
0.050
Why?
Government Agencies
1
2022
15
0.050
Why?
Receptors, Cytoplasmic and Nuclear
1
2023
65
0.050
Why?
Hemorrhage
1
2024
222
0.050
Why?
Choriocarcinoma
2
2012
7
0.050
Why?
Genes, T-Cell Receptor
1
2021
5
0.050
Why?
Uterine Hemorrhage
1
2021
11
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
24
0.050
Why?
Parturition
1
2021
50
0.040
Why?
Phthalazines
1
2021
20
0.040
Why?
Remission Induction
1
2021
218
0.040
Why?
Quinazolines
1
2021
32
0.040
Why?
Lymphocyte Activation
1
2021
160
0.040
Why?
Vulva
1
2020
18
0.040
Why?
Taurine
1
2020
18
0.040
Why?
Research Report
1
2020
19
0.040
Why?
Metabolic Networks and Pathways
1
2021
90
0.040
Why?
Herb-Drug Interactions
1
2020
31
0.040
Why?
Mucin-2
1
2020
8
0.040
Why?
Toxicity Tests
1
2020
57
0.040
Why?
Risk
1
2021
312
0.040
Why?
Alkaline Phosphatase
1
2020
92
0.040
Why?
Piperazines
1
2021
125
0.040
Why?
United States
3
2016
5168
0.040
Why?
Molecular Targeted Therapy
1
2021
132
0.040
Why?
Chemokines
1
2020
78
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2014
580
0.040
Why?
Birth Weight
1
2020
128
0.040
Why?
Preoperative Period
1
2020
47
0.040
Why?
Chorionic Villi
1
2019
3
0.040
Why?
Kruppel-Like Transcription Factors
1
2020
37
0.040
Why?
Pyrimidines
1
2021
198
0.040
Why?
Colon
1
2020
104
0.040
Why?
Endothelium
1
2019
38
0.040
Why?
Mice, Transgenic
2
2014
560
0.040
Why?
Chest Pain
1
2019
57
0.040
Why?
Receptors, Progesterone
1
2020
66
0.040
Why?
Intercellular Adhesion Molecule-1
1
2019
59
0.040
Why?
Ultrasonography, Doppler, Color
1
2019
33
0.040
Why?
Cytochrome P-450 Enzyme System
1
2020
191
0.040
Why?
Glutamine
1
2020
176
0.040
Why?
Dyspnea
1
2019
79
0.040
Why?
Estrogen Receptor alpha
1
2020
85
0.040
Why?
Fatal Outcome
1
2019
192
0.040
Why?
Liver Function Tests
1
2019
48
0.040
Why?
Mice, Inbred Strains
1
2019
163
0.040
Why?
Drug Synergism
1
2019
148
0.040
Why?
Imaging, Three-Dimensional
1
2019
147
0.040
Why?
Gestational Age
1
2020
418
0.040
Why?
Mice, Nude
1
2019
231
0.040
Why?
Xenograft Model Antitumor Assays
1
2019
216
0.040
Why?
Nephrectomy
1
2018
81
0.040
Why?
Mullerian Ducts
1
2018
4
0.040
Why?
Wolffian Ducts
1
2018
2
0.040
Why?
Mutation Rate
1
2018
36
0.040
Why?
Lymph Node Excision
1
2019
133
0.030
Why?
Cell Lineage
1
2018
87
0.030
Why?
Ultrasonography, Prenatal
1
2019
190
0.030
Why?
Mixed Tumor, Mullerian
1
2017
3
0.030
Why?
Skin
1
2020
418
0.030
Why?
DNA Copy Number Variations
1
2018
117
0.030
Why?
Macrophages
1
2019
360
0.030
Why?
Lymph Nodes
1
2019
252
0.030
Why?
Anal Canal
1
2017
27
0.030
Why?
Dietary Supplements
1
2020
467
0.030
Why?
Disease-Free Survival
1
2017
462
0.030
Why?
Matrix Attachment Region Binding Proteins
1
2017
37
0.030
Why?
Child
2
2024
7147
0.030
Why?
Telomerase
1
2016
26
0.030
Why?
Transcriptome
1
2019
363
0.030
Why?
Vaccines, Subunit
1
2016
15
0.030
Why?
Ontario
1
2016
50
0.030
Why?
Mesonephros
1
2016
1
0.030
Why?
Signal Transduction
1
2023
1699
0.030
Why?
Diet
1
2020
600
0.030
Why?
T-Lymphocytes, Regulatory
1
2016
83
0.030
Why?
Anion Exchange Protein 1, Erythrocyte
1
2015
8
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Antiporters
1
2015
19
0.030
Why?
Leukocytes, Mononuclear
1
2016
122
0.030
Why?
S100 Proteins
1
2015
33
0.030
Why?
Cell Count
1
2015
143
0.030
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2015
66
0.030
Why?
Pressure
1
2015
102
0.030
Why?
Cell Hypoxia
1
2015
83
0.030
Why?
Drug Evaluation, Preclinical
1
2015
141
0.030
Why?
Blood Vessels
1
2015
72
0.030
Why?
Receptor Protein-Tyrosine Kinases
1
2015
52
0.030
Why?
Genetic Predisposition to Disease
1
2018
528
0.030
Why?
Prospective Studies
1
2020
2424
0.030
Why?
Random Allocation
1
2015
289
0.030
Why?
Immunoenzyme Techniques
1
2014
135
0.030
Why?
Radiotherapy Dosage
1
2015
253
0.030
Why?
Apoptosis
1
2020
1117
0.030
Why?
Proteome
1
2016
169
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
182
0.030
Why?
Likelihood Functions
1
2014
56
0.030
Why?
In Situ Hybridization, Fluorescence
1
2015
262
0.030
Why?
Multivariate Analysis
1
2015
600
0.030
Why?
Vaccination
1
2016
296
0.030
Why?
Anti-Bacterial Agents
1
2019
796
0.030
Why?
Genes, erbB-1
1
2013
9
0.030
Why?
Lipid Metabolism
1
2014
187
0.030
Why?
Gene Frequency
1
2013
98
0.030
Why?
Adiposity
1
2014
143
0.030
Why?
SEER Program
1
2013
102
0.020
Why?
Mesentery
1
2012
14
0.020
Why?
Communication
1
2015
254
0.020
Why?
Rural Health Services
1
2015
169
0.020
Why?
Insulin Resistance
1
2014
279
0.020
Why?
Neoplasms, Glandular and Epithelial
1
2012
42
0.020
Why?
Research Design
1
2015
367
0.020
Why?
Vascular Endothelial Growth Factor Receptor-3
1
2012
5
0.020
Why?
Diet, High-Fat
1
2014
236
0.020
Why?
Pregnancy Proteins
1
2012
5
0.020
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
7
0.020
Why?
Socioeconomic Factors
1
2015
603
0.020
Why?
Angiopoietin-2
1
2012
14
0.020
Why?
Angiopoietin-1
1
2012
16
0.020
Why?
Ovary
1
2012
103
0.020
Why?
Ivermectin
1
2012
10
0.020
Why?
Antiparasitic Agents
1
2012
11
0.020
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
38
0.020
Why?
Infant
1
2020
3660
0.020
Why?
Algorithms
1
2015
663
0.020
Why?
Hydatidiform Mole
1
2011
2
0.020
Why?
RNA, Messenger
1
2014
1135
0.020
Why?
Interleukin-6
1
2012
274
0.020
Why?
Isoenzymes
1
2011
166
0.020
Why?
Crohn Disease
1
2012
114
0.020
Why?
Promoter Regions, Genetic
1
2012
465
0.020
Why?
Gene Expression
1
2012
618
0.020
Why?
Radiography
1
2011
472
0.020
Why?
Risk Assessment
1
2015
1339
0.020
Why?
Cell Line
1
2012
1018
0.020
Why?
Cohort Studies
1
2013
1541
0.020
Why?
Rats
1
2014
3146
0.020
Why?
DNA Methylation
1
2012
583
0.020
Why?
Blotting, Western
1
2006
588
0.010
Why?
Myocardium
1
2006
477
0.010
Why?
Age Factors
1
2006
1125
0.010
Why?
Quick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description